- Report
- August 2025
- 150 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- October 2025
- 185 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 189 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 191 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 187 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- November 2025
- 247 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- November 2025
- 183 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- October 2025
- 182 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- October 2025
- 188 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- April 2025
- 250 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- April 2025
- 200 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- April 2025
- 200 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- April 2025
- 200 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- July 2025
- 150 Pages
Global
From €2683EUR$3,000USD£2,360GBP
€3354EUR$3,750USD£2,950GBP
- Report
- February 2025
- 149 Pages
Global
From €3533EUR$3,950USD£3,108GBP
- Report
- October 2025
- 150 Pages
Global
From €3444EUR$3,850USD£3,029GBP
- Report
- April 2025
- 125 Pages
Global
From €3687EUR$4,123USD£3,244GBP
€4338EUR$4,850USD£3,816GBP
- Report
- August 2025
- 200 Pages
United States
From €2227EUR$2,490USD£1,959GBP
- Report
- June 2025
- 300 Pages
Europe
From €3461EUR$3,869USD£3,044GBP
- Report
- July 2024
- 156 Pages
Global
From €3231EUR$3,613USD£2,842GBP
€3801EUR$4,250USD£3,344GBP

The Transcatheter Valve Replacement (TVR) market is a subset of the Cardiovascular Devices market. It is a minimally invasive procedure used to replace a diseased or damaged heart valve. The procedure involves inserting a catheter into the patient's body and guiding it to the heart, where the new valve is then deployed. The procedure is less invasive than traditional open-heart surgery, and is often used to treat patients who are at high risk for complications from open-heart surgery.
TVR is a rapidly growing market, with new technologies and procedures being developed to improve patient outcomes. The market is expected to continue to grow as more patients are able to benefit from the procedure.
Some of the companies in the TVR market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and St. Jude Medical. Show Less Read more